Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022March 2, 2022 Emyria saw sales revenue decline by a third in the first six months of the financial […]
Cann Group and Emyria go their separate ways on S3 registration by Martin Lane August 13, 2021August 13, 2021
Emyria granted TGA approval for medical grade, smartphone-enabled, monitoring software by Martin Lane May 13, 2021May 13, 2021
